Le Lézard
Classified in: Health
Subject: SCZ

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Neuromyelitis Optica Spectrum Disorder


ORLANDO, Fla., July 31, 2019 /PRNewswire/ -- The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with neuromyelitis optica spectrum disorder. The program is designed to help eligible individuals pay for their out-of-pocket medical expenses resulting from the condition.

Neuromyelitis optica spectrum disorder, also known as Devic's disease, is a central nervous system disorder that primarily affects the eye nerves and the spinal cord. The disorder can cause blindness in one or both eyes, weakness or paralysis in the legs or arms, painful spasms, loss of sensation, uncontrollable vomiting, and hiccups, and bladder or bowel dysfunction from spinal cord damage.[i]

"People living with neuromyelitis optica spectrum disorder experience significant discomfort and pain related to their condition," said Mark P. McGreevy, President, and CEO, The Assistance Fund. "With the launch of our Neuromyelitis Optica Spectrum Disorder Financial Assistance Program, we are able to help people living with this condition to receive the treatment they need to alleviate their symptoms and enjoy a better quality of life."

To learn more about The Assistance Fund or to determine eligibility for financial support, visit tafcares.org or call (855) 803-6515 to speak with a Patient Advocate.

A complete list of The Assistance Fund's programs is available at tafcares.org.

About The Assistance Fund
The Assistance Fund is an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages more than 60 programs ? each of which covers the FDA-approved medications that treat a specific disease. Since its founding in 2009, The Assistance Fund has helped more than 78,000 adults and children access the medicines they need to stay healthy or manage a chronic condition. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact
Margaret Figley, Director of Communications
[email protected]

[i] "Neuromyelitis optica ? Symptoms and Causes." The Mayo Clinic. (July 19, 2019). Retrieved from: https://www.mayoclinic.org/diseases-conditions/neuromyelitis-optica/symptoms-causes/syc-20375652.

SOURCE The Assistance Fund


These press releases may also interest you

at 10:33
The report titled "Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic Hormone, Calcitonin, Insulin), Route of Administration, Application, End User, Manufacturing Type - Global...

at 10:30
KLOwen Orthodontics continues to lead innovation in the orthodontic industry by launching at AAO, the only custom metal self-ligating (SL) solution available and a 2024 Ortho Innovator Honorable Mention recipient....

at 10:30
For the roughly 1.5 million Americans per year who survive a traumatic brain injury, health outcomes vary widely. Not only can these injuries lead to a loss of...

at 10:18
Richards Packaging Income Fund (the "Fund") announced today its cash distribution for the month ended April 30, 2024 of Cdn$0.11 per unit. This distribution will be to unitholders of record at the close of business on April 30, 2024 and will be...

at 10:15
Sterilization Equipment Market in terms of revenue was estimated to be worth $16.8 billion in 2024 and is poised to reach $24.7 billion by 2029, growing at a CAGR of 7.9% from 2024 to 2029 according to a new report by MarketsandMarketstm. The...

at 10:15
Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that the company will be...



News published on and distributed by: